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As apoptotic pathways are commonly deregulated in breast cancer, exploring how mammary gland cell death is regulated
is critical for understanding human disease. We show that primary mammary epithelial cells from protein kinase C delta
(PKCd) / micehaveasuppressedresponsetoapoptoticagentsinvitro.Inthemammaryglandinvivo,apoptosisiscriticalfor
ductal morphogenesis during puberty and involution following lactation. We have explored mammary gland development in the
PKCd  /  mouse during these two critical windows. Branching morphogenesis was altered in 4- to 6-week-old PKCd  /  mice
as indicated by reduced ductal branching; however, apoptosis and proliferation in the terminal end buds was unaltered.
Conversely, activation of caspase-3 during involution was delayed in PKCd  /  mice, but involution proceeded normally. The
thymus also undergoes apoptosis in response to physiological signals. A dramatic suppression of caspase-3 activation was
observed in the thymus of PKCd  /  mice treated with irradiation, but not mice treated with dexamethasone, suggesting that
therearebothtarget-andtissue-dependentdifferencesintheexecutionofapoptoticpathwaysinvivo.Theseﬁndingshighlighta
role for PKCdin both apoptotic and nonapoptotic processes in the mammary glandand underscore the redundancy of apoptotic
pathways in vivo.
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Apoptosis is an active process of cell death that has a key role
in the development and maintenance of tissue homeostasis.
1
Mammary gland development occurs primarily in the post-
natal period through the process of branching morphogenesis
during puberty, and massive proliferation and secretory
differentiation during pregnancy.
2 During puberty, terminal
endbuds(TEBs)formattheleadingedgeofthegrowingducts
and bifurcate to produce the branched ducts characteristic of
the mature virgin. TEBs are composed of a layer of highly
proliferative cap cells on their distal surface, surrounding a
mass of luminal body cells that undergo high levels of
apoptosis resulting in luminal hollowing.
3,4 Multiple B-cell
leukemia/lymphoma 2 (Bcl-2) family members are expressed
during branching morphogenesis, including antiapoptotic
B-cell leukemia/lymphoma X (Bcl-x), Bcl-2 and B-cell
leukemia/lymphoma w (Bcl-w), as well as the proapoptotic
Bcl-2-associated X protein (Bax) and Bcl-2 homologous
antagonist/killer (Bak) proteins.
5 Mice in which the Bcl-2 gene
is overexpressed have abnormal ductal development, whereas
mice in which the proapoptotic protein, Bcl-2-interacting
mediator of death (Bim), is deleted show delayed apoptosis
in the TEBs, supporting a role for apoptosis during ductal
morphogenesis.
3,6
In addition to early luminal hollowing, apoptosis is also
important for the clearance of epithelial cells during mammary
gland involution. Following the cessation of lactation, large
numbers of secretory mammary epithelial cells (MECs) are
deleted by apoptosis, returning the gland to its prepregnancy
state.
7,8 Quantitative morphometric analysis of epithelial cell
apoptosisandapoptoticcellclearanceduringmammarygland
involution suggests that these processes occur rapidly after
forced weaning and are largely complete by 72–96h.
8 Gene
array studies show an early transient increase in the
expression of death receptor ligands and their receptors
starting 12h after weaning, while increased expression of
regulators of the intrinsic apoptotic pathway, including Apaf1,
Bcl-x, Bak and Bax, and suppression of the death inhibitory
proteins, Bcl-2 and Bcl-w, was observed at 24–96h of
involution.
5,9,10 In mice, loss of Bax or overexpression of
Bcl-2 results in suppression of alveolar cell apoptosis,
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12
Protein kinase Cd (PKCd) is an ubiquitously expressed
isoform of the PKC family of serine/threonine kinases.
13
Studies have identiﬁed diverse roles for this signaling
molecule in control of immunity,
14,15 apoptosis,
16 and cell
migration.
17 Furthermore, its reduced expression in some
human tumors suggests that it may function as a tumor
suppressor.
18,19 Our laboratory and others have shown an
essential role for PKCd in epithelial cell apoptosis induced by
genotoxins, other cell toxins, and death receptors.
16,20–22 The
central role PKCd has in epithelial cell apoptosis suggests
that PKCd may contribute to the regulation of apoptosis in the
mammary gland in vivo. In this study, we have explored
this hypothesis using mice in which the PKCd gene has been
disrupted (dKO). We show that PKCd regulates branching
morphogenesis through nonapoptotic mechanisms in early
mammary gland development. During mammary gland
involution, however, the absence of PKCd results in
delayed apoptosis. Our studies also show that apoptosis in
the thymus displays a similar differential sensitivity to
apoptotic signals, suggesting a redundancy of apoptotic
pathways in vivo.
Results
PKCd expression in the mouse mammary
gland. Development and remodeling of the mammary
gland during puberty and involution require apoptosis, and
thus this tissue is a useful model for exploring regulation
of cell death in vivo. As shown in Figure 1, PKCd protein
is expressed at all stages of the mammary gland
developmental cycle, with the highest levels seen during
mid-pregnancy and during involution. As expected, no PKCd
expression was detected in tissues from dKO mice. In
contrast to PKCd, the expression of PKCa does not vary
during the mammary developmental cycle (Figure 1). The
mammary gland is composed of epithelial, adipose, and
connective tissue. Expression of PKCd in MECs was veriﬁed
by immunoblot of primary MECs isolated from postpubertal
dWT and dKO mice (data not shown). Differential regulation
of PKCd expression in the mammary gland suggests that it
may contribute to the dynamic changes seen in this gland
during pregnancy and involution.
Suppression of apoptosis in primary MECs from dKO
mice. We have previously shown that the loss of PKCd
protects salivary gland cells in vivo from irradiation-induced
cell death; however, the contribution of PKCd to
developmental or physiological programs of cell death is
not known.
22 To assess whether PKCd is required for
apoptosis in MECs, we investigated the effects of
etoposide and integrin detachment on MECs isolated from
dKO or dWT mice. Primary MECs were cultured in vitro and
treated with etoposide. Activation of caspase-3 in MECs from
dKO mice was suppressed by about 50% compared with
MECs isolated from dWT mice, similar to what we have
previously observed in primary salivary epithelial cells
22
(Figure 2a). Loss of integrin engagement (anoikis) induces
apoptosis in epithelial cells and may be an important
apoptotic mechanism during mammary gland involution. To
determine if anoikis is a PKCd-dependent process, MECs
were detached from the culture dish and plated on poly-
hema-coated plates to prevent reattachment. Caspase-3
activation occurs within 4h after plating; however, activation
of caspase-3 was greatly diminished in dKO MECs as
compared with dWT MECs (Figure 2b). Together, this
suggests that PKCd regulates multiple apoptotic pathways
relevant to mammary gland development and maintenance.
Development of the mammary gland during puberty in
dKO mice. Before the onset of puberty the mouse mammary
gland consists of quiescent rudimentary ducts. Under the
inﬂuence of pubertal hormones TEBs form at the leading
edge of the growing ducts and undergo several bifurcation
events to produce the ducts characteristic of the mature
virgin. Body cells within the TEB undergo apoptosis resulting
in a hollow duct for milk ﬂow. To determine if PKCd
contributes to branching morphogenesis, we examined
glands from dKO and dWT mice at 4, 5, 6 and 10 weeks of
age (Figure 3). As seen in Figure 3A, the morphology of
mammary glands from dKO and dWT mice at these
developmental time points appears to be similar.
Immunohistochemical analysis of proliferation and
apoptosis in TEBs from 5-week-old dWT and dKO mice
also showed comparable Ki-67 (proliferation) and active
caspase-3 (apoptosis) staining (Figure 3B). However,
examination of the ductal structure in mammary gland
whole mounts revealed a ductal architecture that is more
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Figure1 ExpressionofPKCdinthemammarygland.MammaryglandswereharvestedfromdWTordKOmiceatthetimepointsindicatedandPKCdorPKCaexpression
wasdeterminedbyimmunoblotanalysisasdescribedinMaterialsandMethodssection.BlotswerestrippedandreprobedfortotalERKexpression(p44andP42)asaloading
control. Samples are as follows: 6 and 10 week virgin mice (6W, 10W); pregnancy day 5 and 15 (P5, P15); lactation day 2 (L2), and involution days 2, 4 and 6 (I2, I4 and I6).
Representative data from three or more mice per time point are shown
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Cell Death and Diseasesimplistic and open in dKO mammary glands relative to dWT
mammary glands (Figure 3C). Notably, ductal branching
appeared to occur less frequently in dKO mammary glands
compared with dWT glands, as relatively long ducts without
side branches were commonly observed in the dKO
mammary glands (Figure 3C; arrows). When these effects
were quantiﬁed we found a small, but signiﬁcant increase in
the distance between primary branch points at 4, 5 and 6
weeks (Figure 3D). As overall duct length did not differ
between the dKO and WT mice (data not shown), we
conclude that branching occurs less frequently in the
mammary glands of dKO mice, indicating that PKCd
contributes to branching morphogenesis in vivo. However,
other pathways eventually compensate for the loss of PKCd,
as the defect in branching in the dKO mice was transient,
with no observable differences at 10 weeks (data not shown).
Importantly, as apoptosis is not reduced, the decreased
branching observed in dKO mice during pubertal
development indicates an apoptosis-independent function
for PKCd in mammary gland development.
Mammary gland involution in dKO mice. To determine if
PKCd contributes to apoptosis during mammary gland
involution, we used a forced-weaning model in which pups
were removed from dams 9 days after parturition. In this
model, lactation is fully established before pup removal and
involution occurs over approximately 2–3 weeks, after which
the gland resembles its prepregnant state. Early involution
(days 1–4) is associated with suppression of milk protein
genes and loss of up to 80% of the secretory epithelial cells.
8
Latter stages are characterized by extensive tissue
remodeling. Mammary gland tissue was harvested from
dWT and dKO mice on days 1 through 8 after weaning (I1 to
I8) and apoptotic cells were identiﬁed by staining with an
antibody that detects active caspase-3. At day 1 of involution
(Figure 4a; I1), there was some shedding of apoptotic
epithelial cells into the lumen, although this is more evident
by involution day 2 (Figure 4a; I2). In mammary glands from
dWT mice, the proportion of cells showing caspase-3
activation peaks at involution day 4 and declines thereafter.
Meanwhile, mammary glands from dKO mice have peak
levels of apoptosis at involution day 6, a 2-day delay
compared with dWT. Quantiﬁcation of active caspase-3-
positive cells (Figure 4b) shows that apoptosis is signiﬁcantly
reduced in mammary glands from dKO mice compared
with dWT mammary glands at day 2 (36% decrease), day 4
(21% decrease) and day 8 (38% decrease) of involution.
In contrast, at involution day 6, activation of caspase-3 in
dKO mice is signiﬁcantly increased relative to dWT mammary
glands. These studies suggest that the kinetics of activation
of caspase-3 during involution is delayed in the dKO mice
relative to dWT mice.
To determine if delayed activation of caspase-3 correlates
with a delay or suppression of mammary gland involution, we
examined mammary gland histology in dWT and dKO mice
up to 21 days after weaning. Lactating glands from both
genotypes show normal alveolar development and secretory
activation (Figure 5, L9). Following pup withdrawal, milk
accumulates within the glands (Figure 5, I1 and I2). Although
the histology of mammary glands from dWT and dKO mice
appears similar at these stages, lipid droplet accumulation in
the dKO glands at I1 was consistently greater compared with
glandsfromdWTmice(seeinset).Byinvolutionday3,mostof
the alveolar structures had collapsed (Figure 5, I3). Mid-to-
late involution is characterized by remodeling of the gland,
which is complete by about 21 days. A comparison of
mammary gland histology at involution days 4, 6, 8, 14 and
21 in dWT and dKO mice shows a loss of secretory alveoli,
a reduction in ductal structures, and an increased ratio of
fat to epithelial cells. Histologically, mammary glands
from dWT and dKO mice appear to be very similar, and
glands from both genotypes are fully regressed by day 21
(Figure 5, I21). However, it was noted that a subset of
mammary glands from dKO mice at involution days 4, 6 and 8
tended to have slightly more epithelial cells and to be more
pleiomorphic with regard to adipocyte size and shape
compared with glands from dWT mice, suggesting that PKCd
may have a role in the composition or organization of the
mammary gland stroma.
Signaltransducerandactivatoroftranscription3(STAT3)is
a critical regulator of mammary gland involution, and mice
with a conditional deletion of STAT3 in the mammary
gland show impairment of epithelial cell apoptosis and
delayed involution.
23–25 STAT3 activation, as determined by
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Figure 2 PKCd regulates apoptosis in MECs in vitro. MECs were prepared from dWT and dKO mice as described in Materials and Methods section. (a) Primary MECs
were treated with etoposide for 16h, harvested and caspase-3 activity assayed as described in Materials and Methods section; dWT, light gray bars; dKO, dark gray bars;
Ut=untreated.Resultsaretheaverageoftriplicatemeasurements±S.E.M.Arepresentativeexperimentisshown(n¼3); *Po0.02byStudent’stwo-tailedt-test.(b)Primary
dWT or dKO MECs were plated on polyhema-coated dishes to prevent attachment and harvested at the indicated times. Top, immunoblot for active caspase-3; bottom, blots
were stripped and immunoblotted for ERK as control for protein loading and transfer. Representative immunoblots are shown (n¼3)
PKC delta and mammary gland
BL Allen-Petersen et al
3
Cell Death and Diseasephosphorylation on Y705, was analyzed to assess if the delay
in caspase-3 activation during involution in dKO glands is due
to aberrant STAT3 signaling. Similar levels of activated
STAT3 are seen in mammary glands from dWT and dKO
mice at L2 and I2, and slightly reduced in mammary gland
tissue from dKO mice at I4 (Figure 6a). To further address
whetherSTAT3activationisalteredinthemammaryglandsof
dKO mice, we analyzed STAT3 Y705 phosphorylation in
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Figure 3 The loss of PKCd leads to defective mammary gland branching morphogenesis. Immunohistochemistry, whole mounts and analysis of branching frequency
were performed as described in Materials and Methods section. (A) Representative pictures ( 40) of mammary glands from 5, 6 and 10 weeks virgin dWT and dKO
micestainedwithH&E.(B)Sections( 400)throughonedWT(a–c)andonedKO(d–f)TEBstainedwithH&E(a,d),orwithantibodiestocleavedcaspase-3(b,e)orKi-67(c,
f). Inset, digital magniﬁcation of area boxed in blue to show cleaved caspase-3-positive cells (b, e) or Ki67-positive cells (c, f). (C) Representative whole mounts of 4th
mammary glands from 4-, 5- and 6-week-old dWT and dKO mice stained with carmine alum. Arrows identify areas of decreased branching in dKO mammary glands as
comparedwithdWT.(D)Thedistancebetweenbranchpointswasquantiﬁedfrom4-week(n¼7),5-week(n¼6)and6-week(n¼5)olddWT(lightgraybars)anddKO(dark
gray bars) mice. The difference between branching frequency in dWT and dKO is signiﬁcant over 4 weeks (*Po0.02), 5 weeks (**Po0.03), and 6 weeks (***Po0.03) by
Student’s two-tail t-test
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Cell Death and Diseaseprimary MECs treated with leukocyte inhibitory factor (LIF)
and interleukin-6 (IL-6), cytokines critical for activation of
STAT3 in the mammary gland during involution.
26 STAT3
activation was nearly identical in dWT and dKO MECs treated
with IL-6 or LIF (Figure 6b). Taken together, our studies
indicate that loss of PKCd results in delayed activation
of caspase-3 during involution, and that this is not due to a
defect in STAT3 activation.
Thymic apoptosis in dKO mice. Although loss of PKCd
results in a delay in caspase-3 activation in the mammary
gland, involution proceeds normally in these mice. In
contrast, irradiation-induced caspase-3 activation is
reduced by 460% in the parotid glands of dKO mice.
22
This suggests that in vivo apoptotic pathways induced by
agents that damage DNA are highly selective for PKCd,
whereas other inducers of apoptosis such as those that
regulate development may be less selective. To further
explore the selectivity of apoptotic pathways for PKCd,w e
compared caspase-3 activation in the thymus in response to
irradiation and dexamethasone treatment. Glucocorticoids
have been shown to induce apoptosis and cause acute
thymic involution in rodents, and this pathway of involution
may be relevant physiologically in response to stress and
inﬂammation.
27,28 dKO or dWT mice were injected with
dexamethasone, the thymus was harvested after 2h, and
active caspase-3 was assayed by immunhistochemistry. As
seen in Figure 7a, dexamethasone is a potent inducer of
apoptosis in the thymus of both dKO or dWT mice; however,
no signiﬁcant difference in caspase-3 activation was found.
In contrast, in response to irradiation of the thymus, caspase-
3 activation is potently induced in dWT, but not dKO mice
(Figure 7b). This ﬁnding suggests that irradiation-induced
apoptosis is highly dependent on PKCd, whereas collateral
apoptotic pathways may be recruited to regulate cell death in
response to other signals, including developmental signals.
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Figure4 LossofPKCddelaysactivationofcaspase-3duringearlyinvolution.(a)MammaryglandtissuewasharvestedfromdWTanddKOmiceatinvolutiondays1–8(I1
to I8), sectioned, and stained with an antibody to active-caspase-3 to identify apoptotic cells. Representative pictures ( 200 magniﬁcation) of each time point are shown
(n¼6 or moremice per timepoint). (b) Caspase-3-positivecells werequantiﬁedas a percentof totalepithelialcells per section. A minimumof 1000 cells fromﬁve ﬁelds were
counted per mouse; six or more mice were analyzed per time point. dWT, light gray bars; dKO, dark gray bars; *differs from dWT Po0.05, ***Po0.001, **Po0.03 by
Student’s two-tailed t-test
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Cell Death and DiseaseDiscussion
PKCd is required for apoptosis in response to cell injury;
21
however,itscontributiontoapoptosisduringdevelopmentand
tissue remodeling has not been addressed. In this study, we
have explored a role for PKCd in the apoptosis of primary
MECs during branching morphogenesis and involution.
In vitro, apoptosis in primary MECs derived from dKO mice
is reduced, and in vivo, activation of caspase-3 during
mammary gland involution is delayed in dKO mice. Loss of
PKCd also results in decreased branching during pubertal
development of the mammary gland; however, this is likely
due to a nonapoptotic function of PKCd. These phenotypic
changes are transient presumably reﬂecting the redundancy
of apoptotic pathways in vivo and the value of proper
mammary gland development to species survival.
Branching morphogenesis requires a delicate balance
between apoptotic and proliferative signals to effectively
establish ductal outgrowth and luminal hollowing. During
puberty, mammary glands from dKO mice are similar in
organization to dWT glands, with hollow lumens and correct
TEB and ductal architecture. Proliferation and caspase-3
activation also appear to be similar in the TEBs of dKO and
dWT mammary glands. This suggests that PKCd either does
not have a signiﬁcant role in the maintenance of cell growth/
deathwithintheTEBorthatlossofPKCdiscompensatedforby
other cell death mechanisms. Brugge and co-workers
6 have
shown that loss of the proapoptotic factor, Bim, suppresses
apoptosis within the TEB resulting in transient luminal ﬁlling;
however, the ducts eventually hollow out by a caspase-
independent mechanism and resemble wild-type mammary
glands. Similarly, overexpression of the antiapoptotic proteins
Bcl2 or Bcl-XL suppresses apoptosis in three-dimensional
culturesofMCF10Acells,butlumenformationstilloccurs.
29As
mammary glanddevelopment andfunction iscriticaltospecies
survival, there is likely to be evolutionary pressure to provide
I6
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Figure5 InvolutioninmammaryglandsfromdKOmice.MammaryglandsfromdWTanddKOmiceatinvolutiondays1–21(I1toI21)werestainedwithH&Easdescribed
inMaterialsandMethodssection.Representativepictures( 100magniﬁcation)areshownfromsixormoremiceanalyzedpertimepoint.Inset,  200magniﬁcationtoshow
lipid accumulation
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Cell Death and Diseasealternative pathways to assure proper mammary gland
function. In the context of ductal morphogenesis, these may
include alternative regulators of apoptosis, as well as non-
apoptotic cell death pathways such as autophagy.
6
Whole mount stains of mammary glands from dKO mice
during puberty show reduced branching during early ductal
morphogenesis; however, by later stages these glands
were indistinguishable from their WT counterparts. Altered
branching morphogenesis has been observed in several
other mouse models within the epithelial and stromal
compartments. Although estrogen receptor,
30 progesterone
receptor,
31 matrix metalloproteinase-2
32 and Src-1
33 have
been shown to be essential for both branching and ductal
outgrowth, other factors, such as eotaxin,
34 primarily regulate
branching. Notably, within the diverse variety of mouse
models that exhibit a branching phenotype, there are very
few cases in which branching morphogenesis is halted
altogether, highlighting the complexity of this process. While
changes in proliferation and apoptosis can affect TEB shape
and its ability to drive ducts through the fat pad, ductal
elongation was not affected in dKO mice. This conﬁrms that
alterations in branching were not due to deﬁciencies in
proliferation or cell death within the TEB. More importantly,
these ﬁndings implicate PKCd in a nonapoptotic role during
ductal morphogenesis.
Our previous studies show that in salivary epithelial cells
PKCd regulates apoptosis upstream of cytochrome c release
and caspase activation in response to genotoxins and other
cell damaging agents.
21,22 In this study, we show that
apoptosis induced by etoposide is similarly suppressed in
primary MECs from dKO mice. Interestingly, activation of
capsase-3 in anoikis, a process possibly relevant to physio-
logical modes of apoptosis, is also suppressed in dKO MECs.
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Figure6 STAT3activationinmammaryglandsfromdKOmice.(a)ProteinlysateswerepreparedfromdWTanddKOmammaryglandsandexpressionofphosphorylated
STAT3(pY705),totalSTAT3andERKwereanalyzedbyimmunoblotasdescribedinMaterialsandMethodssection.(b)PrimaryMECsfromdWTanddKOmicewerestarved
for24hinserum-freeDMEM/F12followedbystimulationwitheitherIL-6orLIF(50ng/ml)fortheindicatedtime;U¼untreated.CellswereharvestedandexpressionofpY705
STAT3 and total STAT3 was analyzed by immunoblot. Representative blots are shown; each experiment was repeated three or more times
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Figure 7 PKCd and apoptosis in the thymus. Thymicinvolution was induced by
dexamethasone(a)orirradiation(b)asdescribedinMaterialsandMethodssection;
UT¼untreated. Tissues were removed and apoptosis detected by immunhisto-
chemistry for active caspase-3. Shown is the average of active caspase-3-positive
cells per  200 ﬁeld. Six ﬁelds were counted per mouse; n¼5 mice per each
genotype for dexamethasone and four mice for irradiation. Signiﬁcantly different
from dWT, *P¼0.0001; dWT, light gray bars; dKO, dark gray bars
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Cell Death and DiseaseOur current studies show that PKCd contributes to the
activation of caspase-3 during mammary gland involution
in vivo; however, suppression of caspase-3 activation is
much greater in cultured primary MECs from dKO mice and
in irradiated dKO salivary glands in vivo.
22 This may be
explained in part by the fact that tissue cell death peaks by
24h postirradiation, while involution occurs over 1–4 days,
possibly allowing activation of redundant cell death programs
to insure successful completion. Alternatively, several studies
indicate that cell death during involution occurs in a series of
sequential steps, perhaps mediated by distinct cell death
pathways.
7,10 PKCd predominantly facilitates intrinsic- or
mitochondrial-mediated cell death, whereas microarray data
suggest that death receptor or extrinsic cell death pathways
regulate the initial wave of apoptosis during involution. If
intrinsic pathways function as a back-up mechanism of cell
death during involution, this may explain the relatively minor
changes in involution seen in the dKO mouse.
Nuclear accumulation of PKCd is an early event in
genotoxin-induced apoptosis that results in the activation of
caspase-3 and ampliﬁcation of the apoptotic signal.
35,36 Our
current studies suggest that apoptosis in vivo is differentially
dependent on PKCd. This suggests that upstream regulators
of apoptosis, such as PKCd, may be differentially activated in
a signal-speciﬁc manner. In this regard, we show that
dexamethasone induces caspase-3 activation in the thymus
to a similar extent in both dKO and dWT mice, while in
response to irradiation, caspase-3 activation is induced
in dWT and not dKO mice. This supports the role of PKCd in
DNA damaging pathways, whereas alternative apoptotic
pathways maybe recruited to facilitate cell death in response
to other stimuli.
The loss of PKCd results in small changes across both
mammary gland pubertal growth and involution. This
suggests that the role of PKCd in the mammary gland is not
restricted to apoptosis, as a reduction in apoptosis is not likely
to explain the decreased ductal branching or decreased
lactation we observe. Furthermore, subtle differences in lipid
composition are evident in the mammary glands of dKO mice,
suggesting that PKCd may have additional roles in mammary
gland homeostasis. This suggests that mammary gland
development and involution are complex biological processes
that are essential for the maintenance and propagation of
mammalian species, thus apoptosis is likely to be regulated at
multiple levels to assure its proper execution.
Materials and Methods
Animals. The PKCd  /  mouse (dKO) on the C57/Bl6 background has been
previously described.
15 Animals were maintained at the University of Colorado
Denver at Anschutz Medical Campus in accordance with Laboratory Animal Care
guidelines and protocols. These studies were conducted with approval of the
University of Colorado Denver Institutional Animal Use and Care Committee. Wild-
type littermates (dWT) were used for all studies. For analysis of mammary gland
involution, pups were removed from mothers at day 9 of lactation.
Mammary gland preparation. Mammary glands were harvested from dWT
ordKOmiceandprocessedforwholemountanalysisorimmunohistochemistry.For
analysis of mammary gland whole-mounts, mammary glands (#4) were spread on
microscope slides and ﬁxed overnight in 10% formalin. Tissues were hydrated,
stained with carmine alum overnight, dehydrated and cleared in xylene for 2h.
Slideswereanalyzedonadissectingscopeanddigitalpictureswereacquiredusing
SPOT imaging software. For quantiﬁcation of branching frequency, the total duct
length of every primary branch, from nipple to distal TEB, was measured in microns
and divided by the total number of branch points within the gland.
For histological andimmunohistochemicalanalysis,contralateral #4 glandswere
ﬁxed in 10% formalin, dehydrated, and embedded in parafﬁn. Five mm sections
were stained with hematoxylin and eosin (H&E). Immunohistochemistry for active
caspase-3 and Ki67 were performed as previously described using primary
antibodies purchased from Cell Signaling Technology, Beverly, MA, USA.
22 Digital
images were acquired using SPOT imaging software.
Immunoblot analysis. Immunoblots were preformed as previously
described.
20 Super Signal West Pico Luminol/Enhancer Solution (Pierce,
Rockford, IL, USA) was used for detection of the signal. Sources of antibodies
were as follows: PKCd and PKCa (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), STAT3, pY705STAT3, active caspase-3, Ki-67 and extracellular signal-
regulated kinase (Cell Signaling Technology).
Primary cell culture. Mammary glands removed from dWT or dKO mice (8–
14 weeks) were minced and digested in Dulbecco’s modiﬁed Eagle medium/F12
(DMEM/F12) containing 2mg/ml collagenase-B, 100U/ml Hyaluronidase, 100U/ml
penicillin-streptomycin (pen/strep), and 100U/ml Gentamicin at 371 for 3h. Primary
MECs were isolated by a series of spins at 1500 and 800r.p.m. and then plated on
collagen 1 (Sigma-Aldrich, St. Louis, MO, USA)-coated plates (2.5 10
5/cm
2)i n
DMEM/F12 supplemented with 10% fetal bovine serum (FBS), 1mg/ml fetuin
(Sigma-Aldrich), 2.5mg/ml insulin, 0.5mg/ml hydrocortisone, 2.5mg/ml epidermal
growth factor (EGF), 25mg/ml gentamicin and 50U/ml Pen/Strep. After 48h, cells
were transferred to growth media (DMEM/F12 supplemented with 2.55mg/ml
insulin, 0.5mg/ml hydrocortisone, 2.5mg/ml EGF, 25mg/ml gentamicin, 50U/ml
pen/strep and 10% FBS). For induction of anoikis, cells were trypsinized and plated
on dishes coated with Polyhema (Sigma-Aldrich). Before treatment with LIF or IL-6,
MECs were plated on Matrigel (BD Biosciences, Bedford, MA, USA) for 24h in
DMEM/F12 supplemented with 10% fetal calf serum, 1mg/ml fetuin (Sigma-
Aldrich), 2.5mg/ml insulin, 0.5mg/ml hydrocortisone, 2.5mg/ml EGF, 25mg/ml
gentamicin and 50U/ml pen/strep, followed by incubation in serum-free growth
media for an additional 24h. LIF was purchased from Calbiochem (San Diego, CA,
USA)andIL-6waspurchasedfromChemicon(Billerica,MA,USA).DMEM/F12and
FBS were purchased from HyClone (Logan, UT, USA); all other reagents for tissue
culture were from Invitrogen (Carlsbad, CA, USA) unless noted otherwise.
Caspase-3 activity. Caspase-3 activity was quantiﬁed using a Biomol
Quantizyme Colormetric Assay Kit (BioMol, Plymouth Meeting, PA, USA) as
previously described.
22 Brieﬂy, caspase-3 activity in 30mg of cell lysate was
measured by cleavage of Ac-DEVD-pNA colormetric substrate, and absorbance at
A405 was quantiﬁed in a microtiter plate reader (Molecular Devices, Sunnyvale, CA,
USA) at 10min intervals for 7h.
Apoptosis in the thymus. For dexamethasome-induced involution, 6-week-
old dWT or dKO male mice (n¼5) were intraperitoneally injected with 0.2mg
dexamethasone (Sigma-Aldrich) dissolved in 100ml endotoxin-free phosphate-
bufferedsaline(PBS)or100mlendotoxin-freePBSalone.Twohoursafterinjection,
mice were killed and the thymus glands harvested. For irradiation-induced
involution, 6-week-old dWT or dKO male mice (n¼4) were subjected to 2Gy
irradiation using a cobalt source. Twenty-hours after irradiation, mice were killed
and the thymus glands harvested and processed for histology and
immunohistochemistry as described.
Miscellaneous. EtoposidewaspurchasedfromSigma-Aldrichanddissolvedin
dimethylsulfoxide.
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